[Cardiac pathology of sudden death].

S. Kawai,R. Okada,Katsumi Miyauchi,Mitsuru Shimizu,Hiromasa Suzuki,Hiroshi Yamaguchi,N. Tashiro,K. Kojima,Y. Mori

DOI: https://doi.org/10.1253/JCJ.58.SUPPLEMENTIV_1123

1995-01-20

Japanese Circulation Journal

Abstract:

What problem does this paper attempt to address?

Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins

Elena Krayukhina,Kouhei Tsumoto,Susumu Uchiyama,Kiichi Fukui

DOI: https://doi.org/10.1002/jps.24184

IF: 3.8

2015-02-01

Journal of Pharmaceutical Sciences

Abstract:Currently, polymer-based prefillable syringes are being promoted to the pharmaceutical market because they provide an increased break resistance relative to traditionally used glass syringes. Despite this significant advantage, the possibility that barrel material can affect the oligomeric state of the protein drug exists. The present study was designed to compare the effect of different syringe materials and silicone oil lubrication on the protein aggregation. The stability of a recombinant fusion protein, abatacept (Orencia), and a fully human recombinant immunoglobulin G1, adalimumab (Humira), was assessed in silicone oil-free (SOF) and silicone oil-lubricated 1-mL glass syringes and polymer-based syringes in accelerated stress study. Samples were subjected to agitation stress, and soluble aggregate levels were evaluated by size-exclusion chromatography and verified with analytical ultracentrifugation. In accordance with current regulatory expectations, the amounts of subvisible particles resulting from agitation stress were estimated using resonant mass measurement and dynamic flow-imaging analyses. The amount of aggregated protein and particle counts were similar between unlubricated polymer-based and glass syringes. The most significant protein loss was observed for lubricated glass syringes. These results suggest that newly developed SOF polymer-based syringes are capable of providing biopharmaceuticals with enhanced physical stability upon shipping and handling.

pharmacology & pharmacy,chemistry, medicinal, multidisciplinary
Development and approval of novel injectables: enhancing therapeutic innovations

Pooja Yadav,Yuvraj Singh,Divya Chauhan,Pavan K Yadav,Ashwini S Kedar,Amrendra K Tiwari,Aarti Abhishek Shah,Jiaur R Gayen,Manish K Chourasia

DOI: https://doi.org/10.1080/17425247.2024.2351987

Abstract:Introduction: Novel injectables possess applications in both local and systemic therapeutics delivery. The advancement in utilized materials for the construction of complex injectables has tremendously upgraded their safety and efficacy. Areas covered: This review focuses on various strategies to produce novel injectables, including oily dispersions, in situ forming implants, injectable suspensions, microspheres, liposomes, and antibody-drug conjugates. We herein present a detailed description of complex injectable technologies and their related drug formulations permitted for clinical use by the United States Food and Drug Administration (USFDA). The excipients used, their purpose and the challenges faced during manufacturing such formulations have been critically discussed. Expert opinion: Novel injectables can deliver therapeutic agents in a controlled way at the desired site. However, several challenges persist with respect to their genericization. Astronomical costs incurred by innovator companies during product development, complexity of the product itself, supply limitations with respect to raw materials, intricate manufacturing processes, patent evergreening, product life-cycle extensions, relatively few and protracted generic approvals contribute to the exorbitant prices and access crunch. Moreover, regulatory guidance are grossly underdeveloped and significant efforts have to be directed toward development of effective characterization techniques.
An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery

Faten Madani,Hassana Hsein,Virginie Busignies,Pierre Tchoreloff

DOI: https://doi.org/10.1080/10837450.2019.1689402

2019-11-24

Pharmaceutical Development and Technology

Abstract:Most of biopharmaceuticals in clinical use today are available in a solution or suspension form and delivered by invasive routes (i.e. injection). However, several attempts have been made in order to develop effective oral formulations of 'biomolecules' characterized by a fragile structure and a low bioavailability. To achieve an efficient delivery of such molecules by non-parenteral route, in particular, via the oral route, novel concepts are needed not only to overcome significant enzymatic and diffusion barriers but also to ensure stability and biological activity. Vaccines and antibodies have a special interest as biomolecules because of their high therapeutic efficacy both in prevention and treatment of several chronic diseases. In this review, we would like to highlight the trends made in the development of pharmaceutical forms to deliver these molecules by the oral route. Hence, we will focus on the description of the different forms (solutions, suspensions, powders, tablets, micro and nanocarriers …) available today or under research study, in which product stability and efficacy are maintained. A special attention will be paid to the formulation strategies that may include the addition of several functional excipients and/or adjuvants, aiming to protect, to functionalize or to modulate their release in the body.

pharmacology & pharmacy
Polymeric-based particulate systems for delivery of therapeutic proteins.

Muhammad Sajid Hamid Akash,Kanwal Rehman,Shuqing Chen

DOI: https://doi.org/10.3109/10837450.2014.999785

2016-01-01

Pharmaceutical Development and Technology

Abstract:Polymeric-based particulate systems have been intensively developed to increase the short biological half-life and prevent enzymatic degradation of therapeutic proteins. These techniques demonstrate the useful characteristics for the delivery of therapeutic proteins and peptides to the targeted site of application and prevent the interaction of encapsulated drug with the normal cells. In this article, we have described the in depth of different pharmaceutical-based techniques that are currently being practiced for efficient delivery of therapeutic proteins and peptides. A comprehensive English literature was searched using different electronic search databases including PubMed, Science Direct, Web of Science, google scholar and library search. Different search terms and advanced search were made by combining all the search fields in abstract, keywords and/or titles. Findings of various studies that have been discussed in this article clearly indicate that polymeric-based techniques can significantly increase the therapeutic potentials of incorporated proteins with no known toxic effects. These techniques have shown to maintain the stability and retain biological activity of protein therapeutics. Hence it can be suggested that pharmaceutical-based techniques are promising drug carriers for efficient delivery of therapeutic proteins.
Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System

Galen H Shi,Ganapathy Gopalrathnam,Sharon L Shinkle,Xia Dong,Jeffrey D Hofer,Eric C Jensen,Natarajan Rajagopalan,Galen H. Shi,Sharon L. Shinkle,Jeffrey D. Hofer,Eric C. Jensen

DOI: https://doi.org/10.5731/pdajpst.2017.008169

2017-10-12

PDA Journal of Pharmaceutical Science and Technology

Abstract:Use of prefilled syringes to self-administer biologics via subcutaneous administration provides convenience to patients. The barrel interior of prefilled syringes is typically coated with silicone oil for lubrication to aid plunger movement at the time of administration. This study intended to evaluate the impact of formulation variables on the silicone oil on the barrel interior surface. Characterization techniques including syringe glide force, break loose force, Schlieren imaging, contact angle, inductively coupled plasma spectrometry, and thin film interference reflectometry were used in assessing the interactions. Data indicated that formulation variables such as pH, buffer/tonicity agent type and concentration, and surfactant present in the formulation can effect silicone oil lubrication of prefilled syringes, leading to changes in functional properties of the syringe over time. Syringe samples containing acetate and histidine buffers showed an increase in glide force at accelerated storage temperature conditions, but the change was minimal at 5 °C. The samples with the highest glide force correlated with the presence of mannitol in combination with sodium acetate buffer. Sodium chloride had lesser impact on glide force than mannitol. Samples with higher glide force exhibited a substantial change in the silicone oil layer of the syringe, as observed with Schlieren imaging, as well as a significant reduction in surface hydrophobicity, as demonstrated through contact angle measurement. These data indicated that the structure of the siliconized surface can change over time in contact with different formulations. During formulation development of drug products in prefilled syringes, in addition to potential impact on molecule stability, the selection of formulation variables should also be guided by assessing the impact to syringe functionality with the glide force as one of the key parameters.<i>LAY ABSTRACT:</i> Self-administering drug products packaged in prefilled syringes provides convenience to patients. The interior of a prefilled glass syringe is typically lubricated with silicone oil for easy plunger movement during injection. This article discusses the impact of formulation excipients on silicone oil coating inside the syringe. Characterization techniques were used to assess the ease of plunger movement and structure of the silicone coating. Data indicate formulation excipients can affect silicone oil distribution of prefilled syringes, leading to an increase in plunger glide force at accelerated storage temperature conditions. The increase in glide force within a prefilled syringe with or without an auto-injector can have an impact on dose accuracy and user experience. Syringes with a higher plunger glide force appeared to exhibit a change over time in surface energy and structure of the silicone oil layer in contact with particular formulations.
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

Samir Mitragotri,Paul A. Burke,Robert Langer

DOI: https://doi.org/10.1038/nrd4363

IF: 112.288

2014-08-08

Nature Reviews Drug Discovery

Abstract:Key PointsBiopharmaceutical drugs such as antibodies, peptides and recombinant proteins have high specificity and potency compared to small molecules. These features arise from their macromolecular composition, which provides the structural complexity that is often required for specificity.However, this structural complexity means that biopharmaceutical drugs are large and susceptible to degradation, which makes it challenging to formulate and deliver them. These drugs also have reduced permeation across biological barriers, which complicates their delivery to specific sites or intracellular targets.In this Review we highlight recent advances in formulation and delivery strategies that have facilitated the transformation of product portfolios and development pipelines by this class of compounds. These advances include the use of microsphere-based sustained-release technologies, protein modification methods that make use of polyethylene glycol and other polymers, as well as genetic manipulation of biopharmaceutical drugs such as Fc- and albumin-fusions.We also highlight current and emerging delivery routes that provide alternatives to injection, including transdermal, oral and pulmonary delivery.Current areas of formulation and delivery research show promise for the application of biopharmaceutical drugs to tumour immunotherapy using nanoparticle technology, tissue engineering and enhanced approaches to cell-based therapy.These delivery methods could be used for the targeted delivery of proteins to the brain, which could have implications in the treatment of a wide range of central nervous system disorders. These technologies could potentially increase the effectiveness of conventional approaches that have not yet translated to the clinic, although they have had promising preclinical results.Intracellular delivery of proteins and peptides is a new frontier in delivery research, which could dramatically augment the breadth of targets amenable to biopharmaceutical drug therapy.

pharmacology & pharmacy,biotechnology & applied microbiology
Conformational studies of chemotactic HCO-Met-Leu-Phe-OMe analogues

G. Vertuani,M. Boggian,A. Breveglieri,G. Cavicchioni,S. Spisani,A. Scatturin

DOI: https://doi.org/10.1007/BF00807274

IF: 3.7891

1995-06-11

Amino Acids

Abstract:
Natural and Synthetic Polymers As Drug Carriers for Delivery of Therapeutic Proteins

Muhammad Sajid Hamid Akash,Kanwal Rehman,Shuqing Chen

DOI: https://doi.org/10.1080/15583724.2014.995806

2015-01-01

Polymer Reviews

Abstract:In order to cure and treat health-related disorders, therapeutic substance must reach its target site with a constant concentration over a long period of time. As oral administration is limited due to enzymatic degradation, most of the commercially available therapeutic proteins are usually being administered parenterally. However, because of their short biological half-life, daily multiple injections are required to maintain effective therapeutic levels of these drug candidates. To limit this drawback, a variety of polymers are being used to increase systemic bioavailability of therapeutic proteins and peptides. Development of protein-based therapeutic substances has tremendously increased the need for suitable polymeric-based carrier systems, guaranteeing safe and sustained delivery of therapeutic proteins to their target site. Here, we have briefly discussed two major types of polymers including natural and synthetic polymers that have been intensively studied for efficient delivery of various proteinous drugs. A wide variety of natural and/or synthetic polymers have been found to be useful and safe drug carrier systems for the delivery of therapeutic proteins which have been discussed over here in detail. To conclude, these polymers have been found to be compatible with most of the incorporated proteins and have shown to have minimal or no toxic profile.
Effect of Various Silicone Oil And Tungsten Levels on the Stability of a Monoclonal Antibody in Nine Commercially Available Prefilled Syringes

Markela Ibo Murphy,Jesse A Leissa,Sandra B Plata,Amy L Chamberlain,Sajal M Patel

DOI: https://doi.org/10.1016/j.xphs.2023.03.009

Abstract:Prefilled syringes are widely used as a primary container for therapeutic proteins because they are more convenient than glass vials. The stability of biologic molecules can be affected by different syringe materials and techniques, such as silicone oil levels and coating method, amount of tungsten remaining in the glass barrel after using a tungsten pin to create the needle hole, and end of the syringe, which can be Luer locked or pre-staked with a needle. We investigated the impact of these parameters by using a monoclonal antibody to collect the antibody's stability profile and the prefilled syringes' functionality data. Silicone oil levels had no impact on aggregation levels, and particle counts were lowest for silicone oil-free syringes. Functionality performance was similar and did not change throughout all stability time points for all syringe configurations. The break-loose force for Ompi syringes was initially lower and increased over time to align with those of the other configurations, all of which remained well below 25 N. Tungsten contaminants and agitation stress from shipping studies did not impact quality attributes. This work can help guide the development of similar products in prefilled syringes to ensure selection of the primary container that provides adequate stability for the protein, as well as maintain the desired functionality features over the shelf life of the drug product.
An expanding horizon of complex injectable products: development and regulatory considerations

Kanan Panchal,Sumeet Katke,Sanat Kumar Dash,Ankit Gaur,Aishwarya Shinde,Nithun Saha,Neelesh Kumar Mehra,Akash Chaurasiya

DOI: https://doi.org/10.1007/s13346-022-01223-5

2022-08-15

Drug Delivery and Translational Research

Abstract:There has been a constant evolution in the pharmaceutical market concerning the new technologies imbibed in delivering drug substances for various indications. This is either market-driven or technology-driven to improve the overall therapeutic efficacy and patients' quality of life. The pharmaceutical industry has experienced rapid growth in the area of complex injectable products because of their effectiveness in the unmet market. These novel parenteral products, viz, the nanoparticles, liposomes, microspheres, suspensions, and emulsions, have proven their worth as "Safe and Effective" products. However, the underlying challenges involved in the development, scalability, and characterization of these injectable products are critical. Moreover, the guidelines available do not provide a clear understanding of these complex products, making it difficult to anticipate the regulatory requirements. Thus, it becomes imperative to comprehend the criticalities and develop an understanding of these products. This review discusses various complexities involved in the parenteral products such as complex drug substances, excipients, dosage forms, drug administration devices like pre-filled syringes and injector pens, and its different characterization tools and techniques. The review also provides a brief discussion on the regulatory aspects and associated hurdles with other parenteral products.

pharmacology & pharmacy,medicine, research & experimental
Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins

Christoph Marschall,Madlen Witt,Bernhard Hauptmeier,Wolfgang Friess

DOI: https://doi.org/10.1016/j.ejpb.2021.01.014

Abstract:Formulating biopharmaceuticals is a challenging task due to their complex and sensitive nature. Protein drugs are typically marketed either as an aqueous solution or as a lyophilizate. Usually aqueous solutions are preferred as neither drying nor reconstitution are required. But it may be unfeasible if the protein features low stability. An interesting alternative to avoid at least reconstitution are protein powder suspensions in non-aqueous vehicles. Such formulations combine the ready-to-use approach with the high protein stability in the solid state. Additionally, protein powder suspensions offer a potentially lower viscosity compared to aqueous solutions at high protein concentrations. Besides injection, other application routes might also benefit from the protein powder approach such as topical or inhalational delivery. Protein powders, which can be dispersed in the non-aqueous suspension vehicle, are usually prepared by spray-drying or freeze-drying with an additional milling step, but other techniques have also been described in literature. An ideal powder preparation technique results in minimum protein damage and yields particle sizes in the lower micrometre range and homogeneous particle size distribution enabling subcutaneous or intramuscular injection through hypodermic needles. As suspension vehicles traditional non-aqueous injectable liquids, such as plant oils, may be selected. But they show an inherent high viscosity, which can lead to unacceptable glide forces during injection. Furthermore, the vehicle should provide high product stability with respect to protein integrity and suspension resuspendability. This review will describe how proteins can be formulated as protein powder suspensions in non-aqueous vehicles for subcutaneous injection including potential vehicles, protein powder preparation techniques, protein and suspension physical stability, as well as the use in the field of high concentration protein formulations.
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery

Rajiv Bajracharya,Jae Geun Song,Seung Yun Back,Hyo-Kyung Han

DOI: https://doi.org/10.1016/j.csbj.2019.09.004

2019-09-11

Abstract:Advancements in biotechnology and protein engineering expand the availability of various therapeutic proteins including vaccines, antibodies, hormones, and growth factors. In addition, protein drugs hold many therapeutic advantages over small synthetic drugs in terms of high specificity and activity. This has led to further R&D investment in protein-based drug products and an increased number of drug approvals for therapeutic proteins. However, there are many biological and biopharmaceutical obstacles inherent to protein drugs including physicochemical and enzymatic destabilization, which limit their development and clinical application. Therefore, effective formulations of therapeutic proteins are needed to overcome the various physicochemical and biological barriers. In current medical practice, protein drugs are predominantly available in injectable formulations, which have disadvantages including pain, the possibility of infection, high cost, and low patient compliance. Consequently, non-invasive drug delivery systems for therapeutic proteins have gained great attention in the research and development of biomedicines. Therefore, this review covers the various formulation approaches to optimizing the delivery properties of protein drugs with an emphasis on improving bioavailability and patient compliance. It provides a comprehensive update on recent advancements in nanotechnologies with regard to non-invasive protein drug delivery systems, which is also categorized by the route of administrations including oral, nasal, transdermal, pulmonary, ocular, and rectal delivery systems.
Glassy Surfactants Enable Ultra-High Concentration Biologic Therapeutics

Carolyn K Jons,Alexander N Prossnitz,Noah Eckman,Changxin Dong,Eric Appel

DOI: https://doi.org/10.1101/2024.09.09.612104

2024-09-13

Abstract:Protein therapeutics, like peptides and antibodies, have become critical to healthcare. Despite their exceptional potency and specificity, biopharmaceuticals are prone to aggregation, often necessitating low formulation concentrations as well as cold storage and distribution to maintain stability. Yet, high doses are required to treat many diseases. To achieve these doses, most approved protein drug products are administered intravenously, imposing excessive burdens on patients and the healthcare system. New approaches are needed to formulate proteins at high concentrations to enable less burdensome subcutaneous injection, preferably in an autoinjector format. To address this challenge, we report a subcutaneously injectable biotherapeutic delivery platform composed of spray-dried protein microparticles suspended in a non-solvent liquid carrier. These microparticles contain only active biopharmaceutical agent and a high glass transition temperature polyacrylamide-derived copolymer excipient affording several key benefits over traditional excipients, including: (i) improved stabilization of biopharmaceuticals through the spray drying process, and (ii) improved morphology and properties of the spray-dried particles, enhancing suspension injectability. Experiments with albumin and human IgG demonstrate that this technology enables ultra-high-concentration protein formulations (exceeding 500 mg/mL) that are injectable through standard needles with clinically relevant injection forces. Additionally, experiments in mice show these ultra-high-concentration formulations reduce required injection volumes without altering pharmacokinetics. This approach could double the number of commercial protein drugs amenable to subcutaneous administration, dramatically reducing burden and improving access to these critical biopharmaceuticals.

Bioengineering
Physicochemical Excipient-Container Interactions in Prefilled Syringes and Their Impact on Syringe Functionality

Liang Fang,Coralie AdÈle Richard,Galen Huaiqiu Shi,Xia Dong,Marissa Rase,Tingting Wang

DOI: https://doi.org/10.5731/pdajpst.2020.012278

2021-01-01

PDA Journal of Pharmaceutical Science and Technology

Abstract:Previous studies have shown that parenteral formulation excipients can interact with the silicone oil in prefilled syringes, thereby causing variations in glide force that affect the performance of autoinjectors. Thus, it is crucial to control the glide force of the prefilled syringes to mitigate the potential risk of dose inaccuracies. This study provided a systematic understanding of the chemical interactions between the excipients, physical interactions between the excipients and the container, as well as their impact on the functional performance of prefilled syringes. The design of experiment approach used in this study generated statistically meaningful data, which confirmed that different excipients caused varying increase in glide force in siliconized prefilled syringes. The data indicated that poloxamer 188 can more effectively maintain stable glide forces during accelerated storage conditions compared with polysorbate 80. This finding was further enhanced using Hansen solubility parameters theory, which provided a fundamental understanding of the mechanisms behind the physical interactions. Chemical stability analysis of the surfactants suggested that degradation of excipients also impacts syringe functionality. In summary, the results revealed the unique interactions between parenteral pharmaceutical excipients and primary packaging systems and the physicochemical foundation behind them.
Polymer-Based Sustained-Release Dosage Forms for Protein Drugs, Challenges, and Recent Advances

Fei Wu,Tao Jin

DOI: https://doi.org/10.1208/s12249-008-9148-3

IF: 3.3

2008-01-01

AAPS PharmSciTech

Abstract:While the concept of using polymer-based sustained-release delivery systems to maintain therapeutic concentration of protein drugs for extended periods of time has been well accepted for decades, there has not been a single product in this category successfully commercialized to date despite clinical and market demands. To achieve successful systems, technical difficulties ranging from protein denaturing during formulation process and the course of prolonged in vivo release, burst release, and incomplete release, to low encapsulation efficiency and formulation complexity have to be simultaneously resolved. Based on this updated understanding, formulation strategies attempting to address these aspects comprehensively were reported in recent years. This review article (with 134 citations) aims to summarize recent studies addressing the issues above, especially those targeting practical industrial solutions. Formulation strategies representative of three areas, microsphere technology using degradable hydrophobic polymers, microspheres made of water soluble polymers, and hydrophilic in vivo gelling systems will be selected and introduced. To better understand the observations and conclusions from different studies for different systems and proteins, physicochemical basis of the technical challenges and the pros and cons of the corresponding formulation methods will be discussed.
A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic

Lloyd Waxman,Vinod D Vilivalam

DOI: https://doi.org/10.5731/pdajpst.2016.007146

Abstract:The development of protein therapeutics requires stabilization of these labile molecules during shipment and storage. Biologics, particularly monoclonal antibodies, are frequently packaged at high concentration in prefillable syringes traditionally made of glass. However, some biologics are unstable in glass due to sensitivity to silicone oil, tungsten, glue, or metal ions. Syringes made from the plastic cyclic olefin polymer, Daikyo Crystal Zenith® (CZ), with a Flurotec-laminated piston, have none of these issues. This study compared the stability of several proteins including biotherapeutics when stored up to 14 months at 5 °C and 25 °C in prefillable siliconized syringes made of glass or silicone oil-free CZ syringes, and when subjected to mild agitation by end-over-end rotation at room temperature. At each time point, proteins were analyzed by several techniques including turbidity, size exclusion high-performance liquid chromatography, reversed phase high-performance liquid chromatography, ion-exchange chromatography, electrophoresis, and light scattering to monitor changes in aggregation and degradation. The results show that proteins have comparable stability when stored in glass syringes or in syringes made of CZ sterilized by E-beam or autoclave. In addition, proteins stressed by agitation were generally more stable and aggregated less in syringes made of CZ than in ones made of glass.LAY ABSTRACT: Biotherapeutic protein drugs such as monoclonal antibodies are frequently packaged at high concentration in prefillable syringes, which allows the drug to be directly administered by the patient or caregiver. Protein drugs, or biologics, can be unstable, and may aggregate, particularly when shaken. These aggregates can be immunogenic, stimulating the body's immune system to produce antibodies that can reduce the drug's efficacy. Although prefillable syringes are traditionally made of glass, some biologics are unstable in glass syringes due to the presence of substances used in their manufacture, including silicone oil, which is necessary for lubricity. Syringes made from the plastic cyclic olefin polymer, Daikyo Crystal Zenith® (CZ), have none of these issues. This study compared the stability of several biotherapeutic proteins when stored up to 14 months at 5 °C and 25 °C in prefillable siliconized syringes made of glass or silicone oil-free CZ syringes, and when mildly agitated at room temperature. Proteins were analyzed by several techniques to detect changes in aggregation and degradation. The results show that biotherapeutic proteins have similar stability whether stored in syringes made of glass or CZ. In addition, proteins subjected to agitation were generally more stable and aggregated less in CZ syringes than in glass syringes.
Development of Stable Injectable Formulation by Freeze Drying Technique

Rajni K,Naresh Kalra,Hunny Dabas

DOI: https://doi.org/10.26452/fjphs.v3i3.500

2023-08-14

Future Journal of Pharmaceuticals and Health Sciences

Abstract:Drug stability is a significant problem that affects drug quality. Freeze drying is one of the techniques that can be used to develop stable drugs. This paper presents a new technique for developing regular drugs by a freeze-drying process with the potential for various applications in and the pharmaceutical industry. This review aims to improve the current systems from unstable to stable by freeze drying technique. systems are dangerous, which leads to the degradation of the drug. The freeze-drying process can be used for sound systems. Characteristics of proteins and peptides are the primary concern of the pharmaceutical industry. Freeze drying provides a new, safe, and effective way to preserve these substances without refrigeration or freezing. In the pharmaceutical industry, many efforts have been made to improve current protein formulations for injection. A new technique called freeze drying is emerging as a potential solution. This paper will explore the characteristics of freeze-drying and its possibilities for developing stable drugs in more detail. Especially complex protein-based drugs present significant challenges to manufacturers because their stability is low, and they often have harsh conditions that need to be stored such as being kept frozen or cooled on ice at all times.
Design and translation of injectable biomaterials

Michael Nguyen,Maria Karkanitsa,Karen L. Christman

DOI: https://doi.org/10.1038/s44222-024-00213-1

2024-08-30

Nature Reviews Bioengineering

Abstract:Injectable biomaterials, including bulk materials and particulate materials, can be delivered in a minimally invasive way and may provide alternative treatment options for conditions that currently require surgical procedures. However, the design and translation of injectable biomaterials can be complex, as the injectability of a biomaterial is determined by its properties and injection conditions, which can change in the translation from the bench to the clinic. In this Review, we highlight parameters that affect the injectability of biomaterials, outlining design considerations for both injectable bulk and particle materials, and examining safety and testing considerations. We then discuss different delivery routes and applications of injectable biomaterials, including subcutaneous, nervous tissue, intraocular, intracardiac, intramuscular and intravascular injection, in addition to orthopaedic applications, highlighting clinically approved approaches and promising preclinical outcomes. Moreover, we survey applications of injectable biomaterials related to women's health, and provide an outlook on the translational challenges and opportunities of injectable biomaterials.
Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

Elisa Berselli,Carlotta Coccolini,Giovanni Tosi,Evren H. Gökçe,M. Beatriz P. P. Oliveira,Faezeh Fathi,Karolline Krambeck,Eliana B. Souto,Krambeck, Karolline

DOI: https://doi.org/10.1007/s10989-024-10592-z

2024-02-29

International Journal of Peptide Research and Therapeutics

Abstract:The delivery of peptides and proteins usually faces formulation development challenges attributed to the difficulties encountered in their stabilization. Nanoparticles offer an alternative to improve the physicochemical stability of such biomacromolecules, while increasing their bioavailability by overcoming biological absorption barriers. With this review, we aim to discuss the stability problems of proteins and peptides that have driven the scientific community to find in nanotechnology a valid alternative for oral administration of biomolecules. In addition, we describe the most commonly used nanoparticles for this purpose (e.g., polymers such as polylactic acid, poly(lactic-co-glycolic acid), polycaprolactone, modified chitosan, and lipids such as oil-in-water nanoemulsions, self-emulsified drug delivery systems, solid lipid nanoparticles, nanostructured lipid carriers, liposomes, as well as hybrid systems like micelles), and we show some of the most important recent applications of these nanoparticles for the delivery of proteins and peptides, including for the treatment of diabetes, viruses (such as HIV), cancer, as well as in the development of vaccines.

biochemistry & molecular biology
Injectability of high concentrated suspensions using model microparticles

Kavin Kowsari,Lynn Lu,Steven C Persak,Guangli Hu,William Forrest,Robert Berger,Jeffrey C Givand,Sahab Babaee

DOI: https://doi.org/10.1016/j.xphs.2024.09.026

2024-10-05

Abstract:Administration of high-concentrated suspension formulations (i.e., solid particles dispersed in a liquid vehicle) can be limited due to their greater propensity for needle occlusion. The physical interaction between the solid phase (i.e., particles), the vehicle (i.e., flow field), and injection devices could result in the formation of particle bridging or filtering, posing a major risk in dose delivery accuracy and injectability. Here, given the limited understanding on how clogging initiates in syringe and needle delivery systems, we report an experimental approach to fully characterize the transient injection behavior of suspensions. In particular, we first established a custom fluorescence tagging and imaging technique with integrated force sensor to enable visual observation of local particle concentrations and plunger force monitoring throughout injection. Then, we investigated the effects of key formulation properties and device parameters including particle concentration and morphology, carrier viscosity, injection rate, needle and syringe sizes, and tissue backpressure on the incidence of suspension particle jamming and needle clogging. We performed systematic benchmark studies demonstrating that increasing needle inner diameter (ID) and particle density considerably reduced clogging risk, while increasing vehicle viscosity, particle size, and tissue backpressure significantly increased clogging. The experimental framework presented is amenable to quantifying clogging risk in drug-loaded particle suspensions and provides a guideline to make informed decisions on the tradeoffs between creating particles for pharmaceutical impact and feasibility of injection delivery.

[Cardiac pathology of sudden death].

Effects of Syringe Material and Silicone Oil Lubrication on the Stability of Pharmaceutical Proteins

Development and approval of novel injectables: enhancing therapeutic innovations

An overview on dosage forms and formulation strategies for vaccines and antibodies oral delivery

Polymeric-based particulate systems for delivery of therapeutic proteins.

Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System

Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

Conformational studies of chemotactic HCO-Met-Leu-Phe-OMe analogues

Natural and Synthetic Polymers As Drug Carriers for Delivery of Therapeutic Proteins

Effect of Various Silicone Oil And Tungsten Levels on the Stability of a Monoclonal Antibody in Nine Commercially Available Prefilled Syringes

An expanding horizon of complex injectable products: development and regulatory considerations

Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins

Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery

Glassy Surfactants Enable Ultra-High Concentration Biologic Therapeutics

Physicochemical Excipient-Container Interactions in Prefilled Syringes and Their Impact on Syringe Functionality

Polymer-Based Sustained-Release Dosage Forms for Protein Drugs, Challenges, and Recent Advances

A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic

Development of Stable Injectable Formulation by Freeze Drying Technique

Design and translation of injectable biomaterials

Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

Injectability of high concentrated suspensions using model microparticles